Can Improved Use of Biomarkers Alter the Fate of PI3K Pathway Inhibitors in the Clinic? - KIVIRID

Can Improved Use of Biomarkers Alter the Fate of PI3K Pathway Inhibitors in the Clinic?

Authors: Emily C. Erickson, Alex Toker

Published: 2021-12-15

DOI: 10.1158/0008-5472.can-21-2035

Source: Full article

Abstract

Abstract